Application of 4-aminopyridine (4-AP) along with excitatory amino acid (EAA) receptor antagonists produces -aminobutyric acid (GABA A ) receptor-dependent synchronized activity in interneurons. This results in waves of activity propagating through upper cortical layers. Since interneurons in the neocortex are excited by nicotinic acetylcholine receptor (nAChR) agonists, ACh may influence synchronization of these local neocortical interneuronal networks. To study this possibility, we have used voltagesensitive dye imaging using the fluorescent dye RH 414 (30 µM) in rat neocortical slices.
INTRODUCTION
The neocortex receives a major cholinergic innervation via cholinergic afferents from the nucleus basalis of Meynert (Mesulam et al. 1983 ). ACh acts via two different types of receptors: muscarinic and nicotinic. Muscarinic receptors are metabotropic and thought to predominantly mediate postsynaptic effects of ACh in the CNS (McCormick and Prince 1986) , although evidence exists for a presynaptic function (Sheridan and Sutor 1990) . Nicotinic ACh receptors (nAChRs) are ligand-gated ion channels that mediate fast excitatory synaptic transmission in the peripheral nervous system. Presence of nAChRs has been detected in different brain regions including the neocortex. Both homomeric and heteromeric receptors exist in the brain (Le Novere et al. 2002; Sargent 1993; Wada et al. 1989 ). Heteromeric 4 2 and homomeric 7 nAChRs are the most abundant and widely expressed nAChRs (Wada et al 1989) . nAChRs in the CNS are important for neuronal development, attention, learning and memory, nocioception and cognition (for review, see: Jones et al. 1999; Levin 2002; Picciotto et al. 2000; Role and Berg 1996) . Neuronal nAChRs play a role in the pathogenesis of brain disorders such as epilepsy, schizophrenia, Alzheimer's disease and Parkinson's disease (for review, see: Lena and Changeux 1997; Lucas-Meunier et al. 2003; Newhouse et al. 1997; Raggenbass and Bertrand 2002) . Linking of human autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) to a mutation in the nAChR 4 subunit (Steinlein et al. 1995 (Steinlein et al. , 1997 underscores the importance of nAChRs in modulation of circuit excitability in the neocortex.
Presynaptic modulation of glutamate release by nAChRs has been demonstrated in the olfactory bulb (Alkondon et al. 1996) , the hippocampus (Gray et al. 1996; Radcliffe JN-00881-2005-R2 4 and Dani 1998) and the prefrontal cortex (Gioanni et al. 1999) . Increases in the release of dopamine, norepinephrine, and serotonin in response to nicotinic stimulation in prefrontal cortex have also been reported (Rao et al. 2003) . Studies in rat hippocampal and human neocortical slices suggest that nAChRs can trigger -aminobutyric acid (GABA) release from interneurons as well Alkondon et al. 1997 Alkondon et al. , 1999 .
Glutamatergic neurotransmission is enhanced by nicotinic agonists in the nucleus accumbens, whereas muscarinic agonists have an opposite effect (Zhang and Warren 2002) . Increases and decreases in EPSCs mediated by nicotinic and muscarinic agonists respectively have also been reported in layers II/III pyramidal neurons of rat PFC Changeux 1989, 1993) . Interneurons can be directly excited by nAChR activation in hippocampus (Frazier et al. 1998; Jones and Yakel 1997) and neocortex (Christophe et al. 2002; Porter et al. 1999; Xiang et al 1998) . The highest laminar densities of cholinergic axons and varicosities are found in layer I of the neocortex (Mechawar et al. 2000) which contains sparsely distributed nonpyramidal neurons (Zhou and Hablitz 1996) . Such dense cholinergic innervation of layer I suggests that this layer may be a major site of cholinergic modulation of neocortical networks.
In the presence of AMPA and NMDA receptor antagonists to block EAA-mediated synaptic transmission, 4-aminopyridine (4-AP) produces depolarizing responses in the neocortex (Aram et al. 1991; Avoli et al. 1994; Benardo 1997) . Such responses are thought to arise from synchronized activity in interneurons mediated by GABA A receptors and are referred to as GABA waves. Electrophysiological (Yang and Benardo 2002 ) and voltage-sensitive dye imaging experiments (DeFazio and Hablitz 2005) suggest that only the superficial layers of the cortex support these responses. Since JN-00881-2005-R2 5 interneurons in the neocortex can be excited via activation of nAChRs (Christophe et al. 2002; Porter et al. 1999; Xiang et al 1998) , ACh may have a role in synchronizing interneuron activity in the neocortex. Using voltage-sensitive dye imaging, we show that endogenous ACh can increase synchronized interneuron activity in local inhibitory circuits in rat prefrontal cortex. This action of ACh requires activation of 4 2-like nAChRs. A preliminary account of these findings has been published in an abstract form (Bandyopadhyay et al., 2004) .
METHODS

Preparation of brain slices
Brain slices from 20-to 42-days old Sprague-Dawley rats were used. Rats were housed and handled according to the guidelines of the NIH Committee on Laboratory Animal Resources. Prior approval from the UAB Institutional Animal Care and Use
Committee was obtained for all experimental protocols. Rats were decapitated under ketamine anesthesia (100 mg/kg, intraperitoneal). After quick dissection, rat brains were placed in ice-cold low-calcium saline containing (in mM): 125 NaCl, 3.5 KCl, 26 NaHCO 3 , 10 D-glucose, 3 MgCl 2 , 1 CaCl 2 . Coronal brain slices (300 µm thick) containing the prefrontal cortex were cut using a Vibratome (Ted Pella, Redding, CA), incubated in recording saline (containing (in mM): 125 NaCl, 3.5 KCl, 26 NaHCO 3 , 10 D-glucose, 2.5 CaCl 2 and 1.3 MgCl 2 ) for 45 minutes at 37 ºC, and then kept at room temperature until recording. The solution was bubbled with a gas mixture containing 95% O 2 and 5% CO 2 to maintain pH around 7.4. Each slice was transferred before recording to a second incubation chamber where they were incubated at room temperature for 30 min in recording saline containing 4-AP (100 µM) and the EAA receptor antagonists D-2-JN-00881-2005-R2 6 amino-5-phosphonvaleric acid (D-APV; 20 µM) and 6-cyano-7-nitro-quinoxaline-2,3-dione (CNQX; 10 µM). Slices were subsequently transferred to a recording chamber continuously perfused (3 ml/min) with recording saline (bubbled with 95%O 2 -5%CO 2 gas mixture) containing 4-AP (100 µM), D-APV (20 µM) and CNQX (10 µM).
Electrophysiological and optical recordings
Neurons in slices were visualized using a Zeiss Axioskop FS (Carl Zeiss, Thornwood, NY) microscope equipped with Nomarski optics, a 40X-water immersion lens and infrared illumination. Layer I neurons were identified by their subpial location.
Biocytin labeling was used to confirm neuronal location and identity. Whole-cell current clamp recordings were obtained as described previously (Bandyopadhyay et al. 2005) .
Patch electrodes were pulled from borosilicate glass capillary tubes and filled with intracellular solution containing (in mM): 125 K-gluconate, 10 KCl, 10 HEPES, 2 Mg-ATP, 0.2 Na-GTP, and 0.5 EGTA (pH = 7.3; osmolarity = 290 mOsm). When filled with this intracellular solution, the patch electrodes had resistances between 3 and 5 M .
Series resistance was less than 20 M in all experiments and was not compensated.
Recordings were discontinued if series resistance increased by more than 20%. The EAA receptor antagonists D-APV (20 µM) and CNQX (10 µM) were bath applied in order to block NMDA and AMPA receptor mediated EPSPs. Bath application of 4-AP (100 µM) in the presence of the EAA antagonists was used to unmask GABA waves in the slice. 
Drug application
Neostigmine, an ACh esterase inhibitor, was used to decrease the degradation of endogenous ACh released upon electrical stimulation in the slice. 1,1-dimethyl-4-phenylpiperazinium iodide (DMPP) was used as a selective nAChR agonist whereas dihydro--erythroidine (DH E) and methyllycaconitine (MLA) were used as nicotinic antagonists.
All the drugs were applied by adding to the bath solution. After recording control responses, neostigmine or DMPP were bath applied for 10-15 minutes. In all experiments in which antagonists were tested, the antagonists were present in both control and agonist-containing solutions unless mentioned otherwise. Drugs were stored in frozen stock solutions and dissolved in the saline prior to each experiment. 4-AP, DMPP, MLA, neostigmine and tetrodotoxin were purchased from Sigma (St. Louis, MO), and D-APV and CNQX from Tocris Cookson (Ellisville, MO).
Data analysis and statistics
Data from imaging experiments were analyzed as described previously (Bandyopadhyay et al. 2005) . A region of interest (ROI) in the control recording was first chosen. The ROI included photodiodes detecting visually obvious activity along with surrounding diodes detecting no apparent activity. The baseline noise level was JN-00881-2005-R2 9 calculated as the average of peak signal amplitudes (peak F/F) of five diodes outside the ROI with no obvious signal. Peak signal amplitude above twice that of the baseline noise was chosen as the threshold value for activity. Diodes in the ROI showing peak signal amplitudes above the threshold were selected for analysis. The sum of the peak signal amplitudes of these diodes are referred to as the 'peak activity'. The estimate of the duration of activity was obtained from the time interval between the first and the last frames of an acquisition showing activity. These parameters were measured in images taken before and 10 minutes after drug application in all the imaging experiments.
Student's t-test was used for statistical comparison (OriginPro 7.0 software) before and after drug application. P < 0.05 was considered significant. Data are expressed as mean ± standard error of mean (SEM).
RESULTS
Evoked GABA waves
Whole-cell current-clamp recordings were obtained from layer I neurons (n = 5) in the prefrontal cortex. Interneurons were identified as fast spiking cells based on action potential width and response to depolarizing current pulses. Biocytin labeling confirmed location in layer I. Intracortical stimulation was used to evoke activity in the presence of D-APV (20 µM) and CNQX (10 µM) to block NMDA-and AMPA-receptor mediated excitation and 4-AP (100 µM) to enhance transmitter release in response to stimulation.
Depolarizing responses with superimposed action potentials of variable amplitudes were observed at resting membrane potentials (-73 ± 2 mV, n = 5). Response amplitudes increased when cells were hyperpolarized by current injection (Fig 1A, upper trace) . Such responses are known to be mediated by GABA A receptors (Aram et al. 1991; Benardo JN-00881-2005 -R2 10 1997 . Bath application of bicuculline (10 µM) blocked the response (n = 5, results not shown). Whole-cell responses were similar in time course to the local field potentials recorded from the superficial layers of the slice (Fig 1A, middle trace) as well as to the optical signals obtained from neocortical slices imaged with the voltage-sensitive dye RH 414 ( Fig 1A, lower trace) . Voltage-sensitive dye imaging has the advantage of detecting activity from a large area of a brain slice suitable for studying activity in a network of neurons. Therefore, imaging with the voltage-sensitive dye RH 414 was utilized to study the effect of stimulus-evoked release of endogenous ACh on spatiotemporal pattern of GABA waves in the neocortex.
Imaging of GABA waves in the neocortex
For imaging, a hexagonal photodiode array containing 464 diodes was utilized. A 5X objective was used in order to cover a large area of the slice (3.5x3.5 mm) reaching from the pia to the white matter. Intracortical stimulation in the presence of D-APV (20 µM), CNQX (10 µM) and 4-AP (100 µM) was used to evoke GABA waves. 
Stimulus-evoked release of endogenous ACh enhances GABA waves in the neocortex
The spatiotemporal distribution of GABA wave activity is shown in Fig 2A . an area of activity that appeared near the stimulating electrode and persisted for 523 ± 26 ms (n = 13) (Fig 2A) . The largest amplitude dye signals were observed in the superficial layers of the cortex and the signal amplitudes gradually decreased in the deeper layers.
The activity spread horizontally through the neocortex in both directions. The extent of spread was variable with 54% of the slices showing spread of activity beyond the imaged area. Similar patterns of activity were seen in experiments (n = 10) with more mature rats (4 to 6 weeks old). In these older animals, 60% of the slices had widespread activity extending beyond the imaged area.
In order to study the effect of endogenous ACh on GABA waves, activity was evoked in the presence of the ACh esterase inhibitor neostigmine (10 µM). At this concentration, neostigmine has been shown to have ACh esterase inhibitor activity in rat brain slices from ventral tegmental area (Calabresi et al., 1989) , dorsal cochlear nucleus (Chen et al., 1998) and nucleus ambiguous (Wang et al., 2003) . After application of neostigmine (10 µM) for 10 minutes, the evoked responses increased in amplitude, persisted for a longer period of time (685 ± 31 ms; n = 13; P < 0.05), and spread horizontally through the upper layers of the cortex out of the imaging area (Fig 2B) . The increase in amplitude of the dye signals following application of neostigmine is evident in the superimposed dye signals from 3 different diodes (Fig 2C) . 'Peak activity' levels (see Methods) were increased from 0.30 ± 0.03 in controls to 0.43 ± 0.04 (n = 13; P < 0.05) after neostigmine application. Thirteen out of 16 slices tested with neostigmine (10 µM) showed a similar pattern of enhancement. This data suggest that endogenously released ACh can enhance the amplitude, duration and spread of depolarizing GABA waves in the neocortex in vitro.
The effect of ACh on GABA waves is mediated by nAChRs
In order to determine the cholinergic receptor type (muscarinic or nicotinic) involved in the enhancement of GABA waves in the neocortex, we tested the effect of the muscarinic ACh receptor antagonist atropine (1 µM). The enhancement by neostigmine (10 µM) of stimulus-evoked GABA waves was not blocked by atropine (1 µM) (Fig 3) .
In the presence of atropine (1 µM), bath application of neostigmine led to an enhancement of activity (n = 7) as seen in experiments without atropine. 'Peak activity' level was significantly higher (0.54 ± 0.09 vs. 0.85 ± 0.20; n = 7; P < 0.05) and duration of activity was significantly prolonged (497 ± 49 ms vs. 677 ± 25 ms; n = 7; P < 0.05) when neostigmine (10 µM) was applied in continued presence of atropine (1 µM) (Fig 5) .
We next used the selective nAChR agonist DMPP under experimental conditions similar to those described above for the neostigmine experiments to determine if the cholinergic enhancement of GABA waves in neocortex was mediated by nAChRs. The selective nAChR agonist DMPP (10 µM) gave rise to the same kind of enhancement of activity (n = 4 of 7 slices tested) as seen after neostigmine application. 'Peak activity' level was significantly higher (0.28 ± 0.05 in control vs. 0.34 ± 0.05 after DMPP; n = 4; P < 0.05) and duration of activity was significantly prolonged (599 ± 95 ms in control vs.
791 ± 93 ms after DMPP; n = 4; P < 0.05) after DMPP application (Fig 5) . Atropine (1 µM) did not have any influence on the effect of DMPP (10 µM) on stimulus-evoked JN-00881-2005-R2 13 GABA responses ('Peak activity': 0.41 ± 0.03 in atropine vs. 0.49 ± 0.05 after DMPP in presence of atropine; n = 4; P < 0.05; duration of activity: 503 ± 33 ms in atropine vs.
663 ± 21 ms after DMPP in presence of atropine; n = 4; P < 0.05). These data suggest that the effect of ACh on GABA waves was mediated by nAChRs.
Cholinergic enhancement of GABA waves require 4 2-like nAChRs
Homomeric 7-like and heteromeric 4 2-like nAChRs are the predominant nicotinic receptor subtypes in the neocortex. To determine the nAChR subtype mediating the effect of ACh observed, we used the nicotinic antagonists MLA and DH E known to selectively block 7-like and 4 2-like nAChRs, respectively. The 7 subunit-selective nAChR antagonist MLA (50 nM) was not effective in blocking the neostigmine effect (Fig 5) . Significant increases in 'peak activity' (0.27 ± 0.01 vs. 0.34 ± 0.01; n = 5; P < 0.05) and duration of activity (420 ± 49 ms vs. 587 ± 17 ms; n = 5; P < 0.05) were still observed when neostigmine (10 µM) was applied in presence of MLA (50 nM). DH E (10 µM), at this concentration known to selectively antagonize 4 2-like nAChRs (Alkondon et al 1999, Alkondon and Albuquerque 2001) , prevented the neostigmineinduced enhancement of GABA waves (Fig 4) . No significant changes in 'peak activity' (0.37 ± 0.04 vs. 0.35 ± 0.04; n = 5; P > 0.05) and duration of activity (517 ± 59 ms vs. 484 ± 64 ms; n = 5; P > 0.05) were seen (Fig 5) when neostigmine (10 µM) was applied in presence of DH E (10 µM).
To test the role of endogenously released ACh the effects of the antagonists selective for 7-like and 4 2-like nAChRs on GABA waves were examined without application of neostigmine. MLA (50 nM) did not have any significant effect on amplitude ('peak activity': 0.24 ± 0.03 vs. 0.23 ± 0.03; n = 5; P > 0.05) or duration (326 ± 55 ms vs. 339 ± JN-00881-2005-R2 14 61 ms; n = 5; P > 0.05) of GABA waves evoked by intracortical stimulation under this condition (Fig 5) . On the other hand, application of DH E (10 µM) resulted in a significant decrease in both 'peak activity' (0.52 ± 0.11 vs. 0.46 ± 0.10; n = 5; P < 0.05) and duration (443 ± 84 ms vs. 345 ± 73 ms; n = 5; P < 0.05) of evoked GABA waves (Fig 5) .
DISCUSSION
The main findings in this study are that stimulus-evoked release of endogenous ACh can enhance the amplitude, duration and spread of depolarizing GABA waves in rat neocortex. Our results indicate that activation of nAChRs, presumably 4 2-like nAChRs, can enhance synchronization of interneurons in the neocortex.
Neocortical GABA waves
Evidence for GABA A receptor-mediated synchronous activity in interneurons was first reported by Aram et al. (1991) after application of the convulsant agent 4-AP in the presence of EAA receptor antagonists. Similar events have also been described in human neocortical slices (Avoli et al 1994) . Imaging with voltage-sensitive dyes has shown that these discharges can give rise to widespread depolarization in slices from hippocampus Ectopic action potentials (abruptly-arising spikes of variable amplitudes occurring below normal spike threshold) during depolarizing GABA responses are more likely to occur in layer I interneurons and may play a role in synchronizing discharge from these JN-00881-2005-R2 15 interneurons (Benardo 1997; Keros and Hablitz 2005) . Synaptic (Tamas et al 1998; Zhou and Hablitz 1996) 
Cholinergic modulation of synaptic transmission in neocortex
Although nAChRs are known to mediate fast excitatory synaptic transmission in the hippocampus (Alkondon et al. 1998; Frazier et al. 1998; Jones and Yakel 1997) McGehee et al 1995; Radcliffe and Dani 1998) and GABA (Alkondon et al 1997 (Alkondon et al , 1999 .
Glutamate release from thalamocortical terminals on to pyramidal cells in rat prefrontal cortex has been shown to be increased by presynaptic nAChR activation Changeux 1989, 1993 Although ACh esterase inhibitors can act as allosteric modulators of nAChRs (Maelicke et al., 1993; Pereira et al., 1994; Schrattenholz et al., 1996; Storch et al., 1995) such modulation is insensitive to blockade by competitive nAChR antagonists like DH E (Pereira et al., 1994; Storch et al., 1995) . A direct effect of neostigmine on nAChRs can be excluded because DH E (10 µM) blocked neostigmine-induced enhancement of evoked GABA waves. DH E (10 µM) also depressed GABA waves evoked in the absence of neostigmine. Direct inhibitory effects of neostigmine on nAChRs, if present, would have attenuated the ACh-induced enhancement of GABA waves. These JN-00881-2005-R2 17 observations lend support to the fact that endogenously released ACh is involved in the enhancement of evoked GABA waves seen in this study.
The cholinergic enhancement of GABA waves was mediated by nAChRs because the effect was mimicked by the nAChR agonist DMPP (10 µM). The DMPP-induced enhancement could be blocked by the nicotinic antagonist DH E (10 µM) but not by the muscarinic antagonist atropine (1 µM). The 4 2 subtype of nAChRs was involved because the nAChR antagonist DH E (10 µM) predominantly blocks 4 2-like nAChRs (Alkondon et al. 1999, Alkondon and Albuquerque 2001 ) and the nicotinic effect was insensitive to blockade by the antagonist MLA (50 nM) selective for 7-like nAChRs (Alkondon et al 1992) .
ACh, synchronized interneuron activity and network oscillations
Networks of GABAergic interneurons can generate synchronous oscillations (Blatow et al 2003; Buzsaki and Chrobak 1995; Fisahn et al 1998) . Synchronization of a mutually interconnected network of interneurons can occur via recurrent collaterals as a result of depolarizations mediated by synaptically activated GABA A receptors as well as electrical coupling between the interneurons (Galaretta and Hestrin 1999; Beierlein et al. 2000; Benardo 1997; Michelson and Wong 1994; Skinner et al 1999) . Oscillations arising out of synchronized interneuron activity may provide a temporal structure for correlated firing of a group of neurons that encodes information in a cortical circuit and phase their firing activity. GABAergic interneurons in hippocampus have the ability to phase spontaneous firing and subthreshold oscillations in pyramidal cells at theta frequencies (Cobb et al 1995) .. Association of hippocampal theta rhythm with exploratory behavior in rodents suggests its involvement in spatial learning and memory (Bland 1986; Larson et JN-00881-2005 -R2 18 al 1986 Huerta and Lisman 1993) . Theta oscillations have also been reported in the neocortex (Bao and Wu 2003; Blatow et al 2003; Raghavachari et al 2001; Sarnthein et al 1998) and bursting discharges from cholinergic basal forebrain neurons have been shown to be associated with theta oscillations (Lee et al 2005) . Cholinergic induction of theta oscillations has been reported in a chemically and electrically coupled network of interneurons in mouse neocortex (Blatow et al 2003) . Thus, cholinergic enhancement of synchronized interneuron activity observed in this study may have a role in theta frequency oscillations in rat neocortex. A B Figure 5 A B A B
